Wondfo Biologics: Announcement of Resolutions of the Eleventh Meeting of the Fifth Supervisory Board
Securities code: 300482 Securities abbreviation: Wondfo Biotech Announcement number: 2025-063 Bond code: 123064 Bond abbreviation: Wondfo Convertible Bonds
Guangzhou Wondfo Biotechnology Co., Ltd.
Announcement of Resolutions of the Eleventh Meeting of the Fifth Supervisory Board
The Company and all members of the Supervisory Board guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
The 11th meeting of the fifth supervisory board of Guangzhou Wondfo Biotechnology Co., Ltd. (hereinafter referred to as the "Company" or the "Company") was held by communication in the company's conference room at 14:00 pm on October 24, 2025. The meeting notice was sent to all supervisors by email or phone on October 17, 2025. Three supervisors should be present at the meeting, and three were actually present. The meeting was held in compliance with the provisions of the Company Law and the Articles of Association. The meeting was chaired by Ms. Peng Leiqing, Chairman of the Company’s Supervisory Board.
After careful deliberation by the supervisors present at the meeting, the following proposals were reviewed and approved at this meeting:
1. Consideration and adoption of the "Proposal on the <Third Quarterly Report of 2025>"
The content of the 2025 third quarter report prepared by the company truly, accurately and completely reflects the actual situation of the company. The preparation process complies with laws, administrative regulations and the relevant provisions of the China Securities Regulatory Commission, and does not contain any false records, misleading statements or major omissions.
The company's "2025 Third Quarter Report" was published on October 27, 2025 on Juchao Information Network (http://www.cninfo.com.cn), the GEM information disclosure website designated by the China Securities Regulatory Commission.
Voting results: 3 votes in favor; 0 votes against; 0 abstentions.
2. Consideration and adoption of the "Proposal on Amending the Articles of Association and Related Rules of Procedure"
In order to further improve the level of standardized operations and improve the corporate governance structure, in accordance with the "Company Law of the People's Republic of China (2023 Revision)" and "Guidelines on the Articles of Association of Listed Companies (2025)" In line with the latest provisions of relevant laws, regulations and normative documents such as the Annual Revision), the company plans to revise the "Articles of Association of Guangzhou Wondfo Biotechnology Co., Ltd." (hereinafter referred to as the "Articles of Association") and its annexes "Rules of Procedure for the Shareholders' Meeting of Guangzhou Wondfo Biotechnology Co., Ltd." and "Rules of Procedure for the Board of Directors of Guangzhou Wondfo Biotechnology Co., Ltd." (hereinafter collectively referred to as the "Rules of Procedure"). The revised "Articles of Association" and its annex "Rules of Procedure" are detailed in the attachment.
At the same time, the company's shareholders meeting is requested to authorize the company's operating management to handle relevant procedures such as amendments to the articles of association, industrial and commercial change registration and filing. The revised "Articles of Association" and its appendix "Rules of Procedure" will become effective and implemented after being reviewed and approved by the company's general meeting of shareholders.
Voting results: 3 votes in favor; 0 votes against; 0 abstentions.
This proposal still needs to be submitted to the second extraordinary general meeting of shareholders in 2025 for review.
Announcement is hereby made.
Board of Supervisors of Guangzhou Wondfo Biotechnology Co., Ltd.
October 24, 2025